Arup Das

Summary

Affiliation: University of New Mexico
Country: USA

Publications

  1. request reprint
    Das A, Boyd N, Jones T, Talarico N, McGuire P. Inhibition of choroidal neovascularization by a peptide inhibitor of the urokinase plasminogen activator and receptor system in a mouse model. Arch Ophthalmol. 2004;122:1844-9 pubmed
    ..Clinical Relevance Inhibition of the protease system (uPA-uPAR) may prove to be a potential novel antiangiogenic therapy for CNV as seen in age-related macular degeneration. ..
  2. Das A, McGuire P, Rangasamy S. Diabetic Macular Edema: Pathophysiology and Novel Therapeutic Targets. Ophthalmology. 2015;122:1375-94 pubmed publisher
    ..Potential novel therapies targeting molecules other than VEGF and using new drug-delivery systems currently are being developed and evaluated in clinical trials. ..
  3. Monickaraj F, McGuire P, Das A. Cathepsin D plays a role in endothelial-pericyte interactions during alteration of the blood-retinal barrier in diabetic retinopathy. FASEB J. 2017;: pubmed publisher
    ..Monickaraj, F., McGuire, P., Das, A. Cathepsin D plays a role in endothelial-pericyte interactions during alteration of the blood-retinal barrier in diabetic retinopathy. ..
  4. Monickaraj F, McGuire P, Nitta C, Ghosh K, Das A. Cathepsin D: an MÏ•-derived factor mediating increased endothelial cell permeability with implications for alteration of the blood-retinal barrier in diabetic retinopathy. FASEB J. 2016;30:1670-82 pubmed publisher
    ..McGuire, P. G., Nitta, C. F., Ghosh, K., Das, A. Cathepsin D: an MÏ•-derived factor mediating increased endothelial cell permeability with implications for alteration of the blood-retinal barrier in diabetic retinopathy. ..
  5. Urias E, Urias G, Monickaraj F, McGuire P, Das A. Novel therapeutic targets in diabetic macular edema: Beyond VEGF. Vision Res. 2017;139:221-227 pubmed publisher
    ..This article summarizes the mechanisms other than VEGF, and how these novel factors can be targeted as promising therapies of DME. ..